Intrauterine devices (IUDs) can increase breast cancer risk by a similar margin compared to contraceptive pills, a recent study found. Image credit: Martí Sans/Stocksy. IUDs are the third most common ...

Metastatic prostate cancer is cancer that began in the prostate but has spread to other parts of the body. There's no cure, but there are a number of effective treatments you can discuss with a ...

Breast cancer is one of the most common cancers affecting women globally. It starts when cells in the breast grow abnormally, often forming a lump or mass. Detecting breast cancer early is crucial for ...

Targeting hormonal therapy for endometrial cancer is opening up the potential to improve outcomes without overtreating in the molecular era. A dramatic increase in endometrial cancer cases and stark ...

For millions of American women, hormone replacement therapy (HRT) has provided relief from side effects of menopause. As the ovaries stop releasing eggs, a woman’s body also stops producing the ...

Orserdu (elacestrant) is a targeted hormonal therapy for breast cancer. Unlike chemotherapy, which can harm both healthy and cancer cells, targeted therapy aims at specific proteins in the cancer ...

When activated in ovarian cancer cells, the receptor for the body's primary stress hormone alters the tumor environment in ...

Women younger than 50 who used a levonorgestrel-releasing intrauterine device (IUD) had a significantly higher risk of breast cancer as compared with women who did not use hormonal contraceptives, a ...

Drs Ursula A. Matulonis and Panagiotis A. Konstantinopoulos discuss hormonal therapy updates and different ways to target and treat ER+ metastatic endometrial cancer. Drs Ursula A. Matulonis and ...

Most gynecologic oncologists and radiation oncologists would consider prescribing hormone therapy for patients with cervical ...